CAMBI ASA NK -,02

Cambi reports a 22% revenue decline for Q2 2026 to NOK 265m and an EBITDA of NOK 26m; gross margin fell to 44%. Operating cash flow rose 44% to NOK 156m, order intake climbed to NOK 554m and the order backlog to NOK 1.5bn. Management expects lower operating profit in 2026 versus 2025 due to project mix and schedules of large contracts, but sees growth potential in the UK, India and New Zealand. The balance sheet remains solid with no long-term debt; however, about 25% of the backlog is conditional. » More on de.investing.com

Cambi reports Q3 2025 revenue falling to 257 million NOK (Q3 2024: 277 million NOK) and an EBITDA of 42 million NOK (down 39% from 68 million NOK). Order intake climbed strongly to 422 million NOK (prior year 117 million NOK) and the order backlog rose to 1.1 billion NOK, while cash and cash equivalents stand at 224 million NOK. The company is introducing new products such as the thermal hydrolysis system Model E, expects a lower operating result for 2026 and announces further growth through international expansion and acquisitions. After the figures were released the stock fell slightly and is trading near its 52-week low. » More on de.investing.com

Cambi ASA reported a 12% increase in revenue to NOK 342m for Q2 2025; at the same time EBITDA fell 8% and the gross margin declined, prompting a sharp drop in the stock after the results. The order backlog remains robust at NOK 938m, the company acquired 51% of C and P Cycles and announced dividend payments, but it sees risks from weakening order intake and regulatory pressure. Management stresses continued underlying demand but expects revenue challenges in 2026. » More on de.investing.com